ImmunoPrecise Antibodies (IPA)
(Delayed Data from NSDQ)
$0.42 USD
-0.06 (-12.47%)
Updated Nov 1, 2024 03:59 PM ET
After-Market: $0.42 0.00 (0.60%) 7:58 PM ET
4-Sell of 5 4
D Value B Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 12/12/24 |
---|---|
Current Quarter | -0.05 |
EPS Last Quarter | -0.11 |
Last EPS Surprise | -22.22% |
ABR | 1.50 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.30 |
Next Year | -0.16 |
EPS (TTM) | -0.78 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (10/2024) |
Next Qtr (1/2025) |
Current Year (4/2025) |
Next Year (4/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 5.11M | 5.33M | 19.71M | 25.42M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 5.11M | 5.33M | 19.71M | 25.42M |
Low Estimate | 5.11M | 5.33M | 19.71M | 25.42M |
Year ago Sales | 4.50M | 4.60M | 18.13M | 19.71M |
Year over Year Growth Est. | 13.56% | 15.87% | 8.73% | 28.97% |
Earnings Estimates
Current Qtr (10/2024) |
Next Qtr (1/2025) |
Current Year (4/2025) |
Next Year (4/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.05 | -0.07 | -0.30 | -0.16 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.05 | -0.07 | -0.30 | -0.16 |
High Estimate | -0.05 | -0.07 | -0.30 | -0.16 |
Low Estimate | -0.05 | -0.07 | -0.30 | -0.16 |
Year ago EPS | -0.07 | -0.08 | -0.78 | -0.30 |
Year over Year Growth Est. | 28.57% | 12.50% | 61.54% | 46.67% |
Agreement - Estimate Revisions
Current Qtr (10/2024) |
Next Qtr (1/2025) |
Current Year (4/2025) |
Next Year (4/2026) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (10/2024) |
Next Qtr (1/2025) |
Current Year (4/2025) |
Next Year (4/2026) |
|
---|---|---|---|---|
Current | -0.05 | -0.07 | -0.30 | -0.16 |
7 Days Ago | -0.05 | -0.07 | -0.30 | -0.16 |
30 Days Ago | -0.05 | -0.07 | -0.30 | -0.16 |
60 Days Ago | -0.04 | -0.06 | -0.25 | -0.14 |
90 Days Ago | -0.04 | -0.06 | -0.25 | -0.14 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (10/2024) |
Next Qtr (1/2025) |
Current Year (4/2025) |
Next Year (4/2026) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.05 | -0.07 | -0.30 | -0.16 |
Zacks Consensus Estimate | -0.05 | -0.07 | -0.30 | -0.16 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (7/2024) |
Quarter Ending (4/2024) |
Quarter Ending (1/2024) |
Quarter Ending (10/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.11 | -0.52 | -0.08 | -0.07 | NA |
Estimate | -0.09 | -0.10 | -0.08 | -0.09 | NA |
Difference | -0.02 | -0.42 | 0.00 | 0.02 | -0.11 |
Surprise | -22.22% | -420.00% | 0.00% | 22.22% | -105.00% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more